The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy
The technology enables clinicians to assess brain tissue and microvascular reperfusion directly in the angiography suite, potentially improving stroke treatment decisions and patient outcomes
The development comes as stroke remains one of the world’s biggest health threats
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Experts also underscored the growing role of technologies such as tele-neurorehabilitation, robotics, and AI-driven therapies in improving recovery outcomes
These results were consistent across all clinically relevant patient subgroups regardless of key patient characteristics like age or sex, the cause of stroke or the severity of the stroke
Millions of stroke survivors across the world may soon have a new defense
The study showed a significant 29% reduction in the risk for heart attack, stroke and death from any cause in the Wegovy users
_256_384.jpg)
Emcure and Dhoni, through a video, urge everyone to be aware about symptoms of stroke and educate at least one person for identification of stroke and spread its awareness
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
